Nordgaard-Lassen I - Search Results

1

Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.

Nordgaard-Lassen I, Dahlerup JF, Belard E, Gerstoft J, Kjeldsen J, Kragballe K, Ravn P, Sørensen IJ, Theede K, Tjellesen L; Danish Society for Gastroenterology. Nordgaard-Lassen I, et al. Dan Med J. 2012 Jul;59(7):C4480. Dan Med J. 2012. PMID: 22759856 Free article.

2

Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.

Bélard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK, Thomsen H, Brylov A, Hetland ML, Nordgaard-Lassen I, Ravn P. Bélard E, et al. Inflamm Bowel Dis. 2011 Nov;17(11):2340-9. doi: 10.1002/ibd.21605. Epub 2011 Feb 11. Inflamm Bowel Dis. 2011. PMID: 21319275

3

Biologic therapy in inflammatory bowel disease.

Theede K, Dahlerup JF, Fallingborg J, Hvas CL, Kjeldsen J, Munck LK, Nordgaard-Lassen I; Danish Society of Gastroenterology and Hepatology. Theede K, et al. Dan Med J. 2013 Jun;60(6):B4652. Dan Med J. 2013. PMID: 23743116 Free article.

4

The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.

Theede K, Kiszka-Kanowitz M, Nielsen AM, Nordgaard-Lassen I. Theede K, et al. Scand J Gastroenterol. 2014 Apr;49(4):418-23. doi: 10.3109/00365521.2014.883427. Epub 2014 Feb 5. Scand J Gastroenterol. 2014. PMID: 24495103

5

[Faecal calprotectin is a useful biomarker for intestinal inflammation].

Theede K, Kiszka-Kanowitz M, Nordgaard-Lassen I, Nielsen AM. Theede K, et al. Ugeskr Laeger. 2014 Sep 8;176(37):V04140213. Ugeskr Laeger. 2014. PMID: 25294035 Free article. Review. Danish.

6

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.

Theede K, Kiszka-Kanowitz M, Nordgaard-Lassen I, Mertz Nielsen A. Theede K, et al. J Crohns Colitis. 2015 Aug;9(8):625-32. doi: 10.1093/ecco-jcc/jjv081. Epub 2015 May 8. J Crohns Colitis. 2015. PMID: 25956537

7

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.

Theede K, Holck S, Ibsen P, Ladelund S, Nordgaard-Lassen I, Nielsen AM. Theede K, et al. Among authors: nordgaard lassen i. Clin Gastroenterol Hepatol. 2015 Nov;13(11):1929-36.e1. doi: 10.1016/j.cgh.2015.05.038. Epub 2015 Jun 4. Clin Gastroenterol Hepatol. 2015. PMID: 26051392

8

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.

Theede K, Holck S, Ibsen P, Kallemose T, Nordgaard-Lassen I, Nielsen AM. Theede K, et al. Among authors: nordgaard lassen i. Inflamm Bowel Dis. 2016 May;22(5):1042-8. doi: 10.1097/MIB.0000000000000736. Inflamm Bowel Dis. 2016. PMID: 26919460

9

Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial.

Kjær MD, Qvist N, Nordgaard-Lassen I, Christensen LA, Kjeldsen J. Kjær MD, et al. Among authors: nordgaard lassen i. Scand J Gastroenterol. 2019 Feb;54(2):188-193. doi: 10.1080/00365521.2019.1569718. Epub 2019 Feb 10. Scand J Gastroenterol. 2019. PMID: 30739519 Clinical Trial.

10

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Attauabi M, Seidelin J, Burisch J; Danish COVID-IBD Study Group. Attauabi M, et al. Gut. 2021 Oct;70(10):2020-2022. doi: 10.1136/gutjnl-2021-324397. Epub 2021 Mar 3. Gut. 2021. PMID: 33658323 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page